Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03068949 · ClinicalTrials.gov registry record · Phase 4
Comparison of Three Licensed Influenza Vaccines
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 413
- Enrollment target
NCT03068949: Completed Phase 4 study, sponsored by University of Rochester.
NCT03068949 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 413 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03068949, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 413 participants
- Enrollment target
Study Summary
This study will evaluate in detail the way that the immune system responds to three different kinds of flu shots that are licensed in the United States.
Primary Outcome
Mean change of HAI serum antibody titers to A/California/07/09 (H1N1) using serum hemagglutination-inhibition (HAI) assay.
Interventions
- BIOLOGICAL Fluzone
- BIOLOGICAL FluBlok
- BIOLOGICAL FluCelVax
- BIOLOGICAL Fluzone HD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2015-10-28 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 4 |
What the finished NCT03068949 record still lists
NCT03068949 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 4 interventions - of which Fluzone is the first listed.
NCT03068949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03068949 about?
NCT03068949 is a clinical study titled "Comparison of Three Licensed Influenza Vaccines". This study will evaluate in detail the way that the immune system responds to three different kinds of flu shots that are licensed in the United States.
What is the current status of trial NCT03068949?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 413 participants. The study started on 2015-10-28. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03068949?
The interventions under investigation include: Fluzone (BIOLOGICAL), FluBlok (BIOLOGICAL), FluCelVax (BIOLOGICAL), Fluzone HD (BIOLOGICAL).
Who is sponsoring clinical trial NCT03068949?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03068949's enrollment target sits among peer trials
413 205th of 2000 higher than 1,796 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI